Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Major Shareholding Notification 2024

Apr 23, 2024

3535_mrq_2024-04-23_b22a659c-d6e9-4c8a-898b-c963c407da99.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - DISCLOSURE OF LARGE SHAREHOLDING

AQUA BIO TECHNOLOGY ASA - DISCLOSURE OF LARGE SHAREHOLDING

23.4.2024 16:47:15 CEST | Aqua Bio Technology ASA | Major shareholding

notifications

Reference is made to the stock exchange notices from Aqua Bio Technology ASA

(the "Company" or "ABT") on 23 April 2024 regarding the amendment agreement

("Amendment Agreement") the Company entered into with Varming Holding AS

("Varming"), and the issuance of 4,708,935 new shares (the "New Shares"), each

at a subscription price of NOK 8.20 per new Share, to settle the share element

in accordance with the Amendment Agreement. The New Shares has today been

resolved by the Company's board of directors pursuant to a board authorization

registered in the Norwegian Register of Business Enterprises on 28 September

2023. The New Shares will be delivered to a separate ISIN pending the Company's

publication of an EEA listing prospectus approved by the Norwegian Financial

Supervisory Authority.

Following Varming's subscription of the New Shares, Varming and close associates

will own a total of 4,976,704 shares and votes in the Company, representing

approximately 8.49% of the outstanding votes and shares in the Company, and has

thereby exceeded the 5 % threshold pursuant to section 4-2 of the Norwegian

Securities Trading Act.

This information is subject to the disclosure requirements in article 19 of the

Regulation EU 596/2014 and sections 4-2 and 5-12 of the Norwegian Securities

Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/3056/4365/Download%20announcement

%20as%20PDF.pdf